INTERVAL study: To determine whether the interval between blood donations in England can be safely and acceptably decreased
- Conditions
- Optimum intervals for blood donationNot Applicable
- Registration Number
- ISRCTN24760606
- Lead Sponsor
- HS Blood and Transplant (NHSBT) (UK)
- Brief Summary
2014 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/25230735 2016 results in: https://www.ncbi.nlm.nih.gov/pubmed/27645285 2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/28941948 2019 extension study results in: https://www.ncbi.nlm.nih.gov/pubmed/31383583 (added 07/08/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 50000
1. Age >17 years and fulfilling all normal criteria for blood donation
2. Willing to be assigned to any of the study intervention groups
3. Registered at one of the permanent donation clinics at the time of enrolment
Current exclusion criteria as of 22/05/2012:
1. As the aim of the study is to be almost ?paper-less?, it will involve remote web-based data collection. Hence, participants who do not have internet access and/or are not willing to provide an email address for study correspondence will be excluded
Previous exclusion criteria:
1. Donors who are providing extra samples to NHSBT at their initial visit (e.g. for the British bone marrow registry) as there will be insufficient blood left in the sample pouch for the collection of study samples
2. As the aim of the study is to be almost ?paper-less?, it will involve remote web-based data collection. Hence, participants who do not have internet access and/or are not willing to provide an email address for study correspondence will be excluded
3. Donors who have been identified for ?special panels? by NHSBT
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total blood collected after two years, expressed in units (470ml) per person per year
- Secondary Outcome Measures
Name Time Method <br> Assessed two years after recruitment and will include:<br> 1. Donor quality of life using the SF-36 health survey (this is the key secondary outcome)<br> 2. Number of donation 'deferrals' (i.e. temporary rejections) of donors due to low haemoglobin and other factors<br> 3. Markers of iron status (serum ferritin and reticulocyte haemoglobin)<br> 4. Cognitive ability (reasoning, attention and memory)<br> 5. Levels of physical activity<br> 6. Cost effectiveness<br> 7. Donor attitudes, beliefs and values<br>